Novartis AG (NVSEF)
OTCMKTS · Delayed Price · Currency is USD
140.22
-6.87 (-4.67%)
At close: Jan 16, 2026
Novartis AG Market Cap
Novartis AG has a market cap or net worth of $276.38 billion as of January 16, 2026. Its market cap has increased by 41.87% in one year.
Market Cap
276.38B
Enterprise Value
299.01B
Revenue
56.37B
Ranking
n/a
PE Ratio
19.20
Stock Price
$140.22
Market Cap Chart
Since March 2, 1998, Novartis AG's market cap has increased from 127.35B to 276.38B, an increase of 117.03%. That is a compound annual growth rate of 2.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 276.38B | 3.90% |
| Dec 30, 2025 | 266.00B | 36.05% |
| Dec 30, 2024 | 195.51B | -5.62% |
| Dec 29, 2023 | 207.17B | 6.54% |
| Dec 30, 2022 | 194.45B | -1.02% |
| Dec 30, 2021 | 196.46B | -8.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 831.36M |
| Glass House Brands | 739.20M |
| Elite Pharmaceuticals | 511.53M |
| Northwest Biotherapeutics | 446.47M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 335.01M |
| Silence Therapeutics | 262.62M |